Latest Insider Transactions at Aveanna Healthcare Holdings, Inc. (AVAH)
This section provides a real-time view of insider transactions for Aveanna Healthcare Holdings, Inc. (AVAH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aveanna Healthcare Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aveanna Healthcare Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 29
2024
|
Jerry Perchik |
BUY
Grant, award, or other acquisition
|
Direct |
162,500
+50.0%
|
-
|
Feb 21
2024
|
Deborah Stewart SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,680
+20.97%
|
-
|
Feb 21
2024
|
Matthew Buckhalter Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149,897
+31.14%
|
-
|
Feb 21
2024
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
124,482
+9.34%
|
-
|
Feb 21
2024
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
62,241
+2.91%
|
-
|
Feb 21
2024
|
Victor F Ganzi |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+10.59%
|
-
|
Feb 21
2024
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,568
+15.81%
|
-
|
Feb 21
2024
|
Richard C Zoretic |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+17.76%
|
-
|
Feb 21
2024
|
Jeff Shaner |
BUY
Grant, award, or other acquisition
|
Direct |
518,154
+19.28%
|
-
|
Feb 21
2024
|
Erica Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+19.05%
|
-
|
Feb 21
2024
|
Sheldon M Retchin |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+15.39%
|
-
|
Feb 21
2024
|
Steven E Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
53,942
+16.9%
|
-
|
Feb 14
2024
|
Steven E Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+32.81%
|
-
|
Feb 14
2024
|
Sheldon M Retchin |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+29.84%
|
-
|
Feb 14
2024
|
Richard C Zoretic |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+34.51%
|
-
|
Feb 14
2024
|
Victor F Ganzi |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+20.45%
|
-
|
Feb 14
2024
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
103,175
+37.05%
|
-
|
Feb 14
2024
|
Rodney D Windley |
BUY
Exercise of conversion of derivative security
|
Direct |
119,048
+5.57%
|
-
|
Aug 15
2023
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+46.07%
|
-
|
Aug 15
2023
|
Victor F Ganzi |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+17.12%
|
-
|
Aug 15
2023
|
Sheldon M Retchin |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+30.66%
|
-
|
Aug 15
2023
|
Richard C Zoretic |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+39.95%
|
-
|
Aug 15
2023
|
Steven E Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
61,611
+36.3%
|
-
|
Jun 06
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
200
+0.08%
|
$200
$1.23 P/Share
|
Jun 01
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
3,200
+1.34%
|
$3,200
$1.18 P/Share
|
May 31
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
11,850
+4.84%
|
$11,850
$1.15 P/Share
|
May 30
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
1,758
+0.79%
|
$1,758
$1.14 P/Share
|
Feb 14
2023
|
Jeff Shaner |
BUY
Grant, award, or other acquisition
|
Direct |
421,094
+20.34%
|
-
|
Feb 14
2023
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+14.79%
|
-
|
Feb 14
2023
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,594
+24.01%
|
-
|
Feb 14
2023
|
Beth Rubio Chief Nursing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,313
+26.02%
|
-
|
Feb 14
2023
|
David Afshar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
314,688
+34.29%
|
-
|
Feb 14
2023
|
Shannon Drake Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+31.97%
|
-
|
Feb 14
2023
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
119,048
+5.9%
|
-
|
Aug 24
2022
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.35%
|
$20,000
$2.01 P/Share
|
Jun 30
2022
|
Richard C Zoretic |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+25.31%
|
-
|
Jun 30
2022
|
Sheldon M Retchin |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+11.91%
|
-
|
Jun 30
2022
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+50.0%
|
-
|
Jun 30
2022
|
Victor F Ganzi |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+4.57%
|
-
|
Jun 30
2022
|
Steven E Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+18.43%
|
-
|
May 26
2022
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Open market or private purchase
|
Direct |
3,100
+2.47%
|
$9,300
$3.1 P/Share
|
May 20
2022
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Open market or private purchase
|
Direct |
9,000
+1.0%
|
$18,000
$2.88 P/Share
|
May 19
2022
|
Rodney D Windley |
BUY
Open market or private purchase
|
Direct |
36,000
+2.1%
|
$72,000
$2.9 P/Share
|
May 19
2022
|
Jeff Shaner |
BUY
Open market or private purchase
|
Direct |
9,000
+0.73%
|
$18,000
$2.9 P/Share
|
May 19
2022
|
Tony Strange Director |
BUY
Open market or private purchase
|
Direct |
36,000
+2.1%
|
$72,000
$2.9 P/Share
|
May 18
2022
|
Steven E Rodgers |
BUY
Open market or private purchase
|
Direct |
6,000
+14.29%
|
$12,000
$2.7 P/Share
|
May 17
2022
|
Steven E Rodgers |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$60,000
$2.84 P/Share
|
May 16
2022
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
12,036
+4.23%
|
$24,072
$2.86 P/Share
|
Feb 14
2022
|
Tony Strange Director |
BUY
Grant, award, or other acquisition
|
Direct |
268,509
+12.3%
|
-
|
Feb 14
2022
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
268,509
+12.31%
|
-
|